当前位置: 首页 > 期刊 > 《中外医疗》 > 201113
编号:13768843
肾嫌色细胞癌的诊治和预后
http://www.100md.com 2011年5月5日 《中外医疗》 201113
 ,肾嫌色细胞癌诊断治疗
     【摘要】  目的分析肾嫌色细胞癌的临床特点。方法结合文献回顾性分析我院2002年至2009年16例肾嫌色细胞癌的病历资料。结果14例行根治性肾切除,2例行肾部分切除术;TNM分期:T1aN0M05例、T1bN0M05例、T2N0M06例;13例获随访,随访6~84个月,平均46个月,无肿瘤复发、转移和死于肾癌的患者。结论肾嫌色细胞癌是一种少见的低度恶性肾细胞癌,预后较好。影像学检查对其诊断具有重要作用,确诊依赖于病理检查,治疗以手术为主,保留肾单位手术适用于大多数病例。

    【关键词】 肾嫌色细胞癌诊断治疗

    【中图分类号】 R737.11【文献标识码】 A【文章编号】 1674-0742(2011)05(a)-0019-02

    【Abstract】 ObjectiveTo analyze the clinical characteristics of renal chromophobe cell carcinoma(CRCC).MethodsA retrospective review of 16 cases of CRCC between 2002 and 2009.Results14 cases underwent radical nephrectomy,2 casesunderwent partial nephrectomy.TNM classification:T1aN0M0 5 cases,T1bN0M0 5 cases,T2N0M0 6 cases.13 cases were followed up for 6 to 84 months, no case had experienced tumor recurrence or metastasis,and none had died of renal carcinoma.ConclusionCRCC is a rare subtype renal cell carcinoma which exhibits low-degree m alignancy with favorable prognosis.Imaging plays an important role in the diagnosis of CRCC.Definite diagnosis depends on pathological examination.Surgical excision is the mainstay of therapy in non-metastatic CRCC and partial nephrectomy is advocate whenever it is feasible. ......

您现在查看是摘要页,全文长 5774 字符